000 | 01380 a2200373 4500 | ||
---|---|---|---|
005 | 20250514005225.0 | ||
264 | 0 | _c20010913 | |
008 | 200109s 0 0 eng d | ||
022 | _a0022-3565 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEdwards, R M | |
245 | 0 | 0 |
_aDopamine inhibits vasopressin action in the rat inner medullary collecting duct via alpha(2)-adrenoceptors. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cSep 2001 |
||
300 |
_a1001-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacology |
650 | 0 | 4 |
_aClozapine _xpharmacology |
650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
650 | 0 | 4 |
_aDopamine _xpharmacology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aKidney Medulla _xdrug effects |
650 | 0 | 4 |
_aKidney Tubules, Collecting _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNorepinephrine _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Adrenergic, alpha-2 _xdrug effects |
650 | 0 | 4 |
_aVasopressins _xantagonists & inhibitors |
650 | 0 | 4 |
_aYohimbine _xpharmacology |
700 | 1 | _aBrooks, D P | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 298 _gno. 3 _gp. 1001-6 |
|
999 |
_c11429904 _d11429904 |